For example, studies have confirmed that high-grade endometrioid adenocarcinoma has great heterogeneous, POLE mutations are significantly associated with favorable clinical outcomes in high-grade endometrioid endometrial cancer, which implies that high-grade endometrioid endometrial cancer should be reevaluated by molecular parameters (32). Here, POLE is linked to endometrioid adenocarcinoma.